HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Piyarat Govitrapong Selected Research

Parkinsonian Disorders (Parkinsonism)

5/2008Melatonin inhibits amphetamine-induced increase in alpha-synuclein and decrease in phosphorylated tyrosine hydroxylase in SK-N-SH cells.
5/2007Zinc protects SK-N-SH cells from methamphetamine-induced alpha-synuclein expression.
5/2005Mechanism of 1-methyl-4-phenylpyridinium-induced dopamine release from PC12 cells.
11/20031-Methyl-4-phenylpyridinium-induced down-regulation of dopamine transporter function correlates with a reduction in dopamine transporter cell surface expression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Piyarat Govitrapong Research Topics

Disease

33Neuroblastoma
10/2023 - 09/2006
20Inflammation (Inflammations)
11/2023 - 09/2009
16Alzheimer Disease (Alzheimer's Disease)
05/2022 - 01/2011
12Neurodegenerative Diseases (Neurodegenerative Disease)
11/2023 - 10/2010
12Neuroinflammatory Diseases
10/2023 - 02/2013
10Parkinson Disease (Parkinson's Disease)
05/2015 - 04/2004
8Cognitive Dysfunction
06/2023 - 11/2013
6Mitochondrial Diseases (Mitochondrial Disease)
07/2023 - 12/2008
4Virus Diseases (Viral Diseases)
11/2023 - 10/2019
4Gliosis
01/2022 - 08/2012
4Neoplasms (Cancer)
12/2021 - 12/2007
4Amyloid Plaque
01/2019 - 01/2011
4Parkinsonian Disorders (Parkinsonism)
05/2008 - 11/2003
3Brain Ischemia (Cerebral Ischemia)
10/2023 - 01/2017
3Reperfusion Injury
10/2023 - 01/2017
3Infarction (Infarctions)
01/2022 - 01/2017
3Memory Disorders (Memory Loss)
01/2020 - 10/2011
3Glioma (Gliomas)
01/2017 - 04/2014
3Pain (Aches)
01/2013 - 09/2002
2Hyperglycemia
09/2022 - 01/2020
2Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
02/2022 - 01/2022
2Brain Injuries (Brain Injury)
01/2022 - 01/2010
2Ischemic Stroke
01/2021 - 01/2017
2Obesity
01/2021 - 06/2017
2Dementia (Dementias)
01/2019 - 01/2016
2Body Weight (Weight, Body)
06/2017 - 11/2013
2Substance-Related Disorders (Drug Abuse)
10/2008 - 03/2006
1Stroke (Strokes)
10/2023
1Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy)
06/2023
1Infections
01/2023
1Anemia
01/2023
1B-Cell Lymphoma (Lymphoma, B Cell)
01/2022
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2021
1Lung Neoplasms (Lung Cancer)
12/2021
1COVID-19
01/2021

Drug/Important Bio-Agent (IBA)

53MelatoninIBA
10/2023 - 01/2005
23Methamphetamine (Desoxyn)FDA LinkGeneric
01/2023 - 03/2006
22Proteins (Proteins, Gene)FDA Link
11/2023 - 05/2008
11Peptides (Polypeptides)IBA
06/2023 - 06/2005
11Amyloid (Amyloid Fibrils)IBA
08/2022 - 01/2011
8Reactive Oxygen Species (Oxygen Radicals)IBA
05/2022 - 12/2008
6Amyloid beta-PeptidesIBA
10/2023 - 01/2016
5CaspasesIBA
10/2023 - 05/2009
5agomelatine (S20098)IBA
07/2023 - 01/2017
5Amyloid Precursor Protein Secretases (beta-Secretase)IBA
01/2019 - 01/2011
5calpastatinIBA
01/2018 - 01/2012
5NeurotoxinsIBA
02/2014 - 04/2004
4CytokinesIBA
10/2023 - 12/2016
4Melatonin Receptors (Melatonin Receptor)IBA
09/2022 - 09/2015
4Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
01/2020 - 01/2009
4Dexamethasone (Maxidex)FDA LinkGeneric
01/2016 - 10/2011
4CalpainIBA
01/2016 - 03/2010
4Amphetamine (Amfetamine)FDA LinkGeneric
08/2012 - 08/2007
3EnzymesIBA
01/2023 - 01/2019
3Hormones (Hormone)IBA
01/2023 - 01/2016
3Neuroprotective AgentsIBA
01/2022 - 01/2009
3Insulin (Novolin)FDA Link
01/2020 - 09/2013
3CalcineurinIBA
01/2020 - 01/2016
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2023 - 03/2020
2InflammasomesIBA
10/2023 - 06/2023
2Interleukin-18 (Interleukin 18)IBA
10/2023 - 01/2023
2Peptide Hydrolases (Proteases)FDA Link
10/2023 - 01/2016
2Antiviral Agents (Antivirals)IBA
01/2023 - 01/2021
2Biomarkers (Surrogate Marker)IBA
01/2023 - 06/2017
2Interleukin-6 (Interleukin 6)IBA
01/2023 - 03/2020
2Glucose (Dextrose)FDA LinkGeneric
09/2022 - 06/2017
2DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA
01/2022 - 01/2017
2Anti-Inflammatory Agents (Anti-Inflammatories)IBA
12/2021 - 09/2009
2GlucocorticoidsIBA
05/2021 - 11/2013
2NF-kappa B (NF-kB)IBA
03/2020 - 03/2007
2Caspase 3 (Caspase-3)IBA
10/2019 - 01/2017
2CalciumIBA
01/2016 - 09/2015
2AntioxidantsIBA
07/2015 - 02/2013
2Dopamine (Intropin)FDA LinkGeneric
02/2013 - 02/2009
2Transcription Factors (Transcription Factor)IBA
02/2013 - 01/2012
2Reactive Nitrogen SpeciesIBA
02/2013 - 05/2010
2Dextroamphetamine (Dexedrine)FDA LinkGeneric
08/2012 - 08/2007
2alpha-SynucleinIBA
01/2012 - 05/2008
2Messenger RNA (mRNA)IBA
11/2011 - 12/2007
2EmetineIBA
11/2011 - 12/2007
2Free RadicalsIBA
12/2008 - 11/2005
2salsolinolIBA
03/2007 - 04/2004
21-Methyl-4-phenylpyridinium (1 Methyl 4 phenylpyridinium)IBA
05/2005 - 11/2003
1Neurotransmitter Agents (Neurotransmitter)IBA
11/2023
1Aspartic Acid (Aspartate)FDA Link
10/2023
1ElementsIBA
10/2023
1Caspase 1 (ICE Protease)IBA
10/2023
1NLR ProteinsIBA
10/2023
1Sirtuin 1IBA
06/2023
1Brain-Derived Neurotrophic Factor (BDNF)IBA
01/2023
1EndotoxinsIBA
01/2023
1Tryptophan (L-Tryptophan)FDA Link
01/2023
1huperzine AIBA
05/2022
1Cholinergic Agents (Cholinergics)IBA
05/2022
1Therapeutic UsesIBA
05/2022
1Malondialdehyde (Propanedial)IBA
01/2022
1Minocycline (Cyclops)FDA LinkGeneric
12/2021
1Acetylcholine (Acetylcholine Chloride)FDA Link
12/2020
1Muscarinic M4 ReceptorIBA
12/2020

Therapy/Procedure

3Therapeutics
03/2020 - 01/2010